PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
33.9% below 52-week high
25.18
16.6652W Low
38.1152W High
1 Week
2.6% below 1-week high
23.031W Low
25.841W High
PROCEPT BioRobotics Corporation - Common Stock (PRCT) traded between $16.66 and $38.11 over the past 52 weeks and last traded at $25.18, 33.9% below its 52-week high. Over the past week it ranged between $23.03 and $25.84.
Past 12 Months
1W
+$1.67
1M
+$6.90
3M
+$3.27
6M
-$2.93
YTD
-$5.58
1Y
-$3.22
PRCT was -11.3% over the past year, -10.4% over six months, -18.1% year to date, +7.1% in the last week.
12 Months vs Market
PRCT
DIA
SPY
QQQ
IWM
Over the past 12 months PRCT returned -11.3% versus DIA (Dow) +8.8%, SPY (S&P 500) +10.6%, QQQ (Nasdaq 100) +10.6% and IWM (Russell 2000) +15.7%.
Volume & Liquidity
1.59× 3-mo avg
Today 2,048,997
3-mo avg 1.3M
1W
1M
3M
6M
YTD
1Y
PRCT most recently traded 2,048,997 shares against a 3-month average daily volume of 1.3M. More NewsRead MoreFrequently Asked QuestionsIs PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 25.18
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 11/18/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||